Monday, July 10, 2017

Considering the Side Effects of Drugmakers’ Money-Back Guarantees


By KATIE THOMAS and CHARLES ORNSTEIN from NYT Health Considering the Side Effects of Drugmakers’ Money-Back Guarantees
The Trump administration is considering encouraging lowering drug costs through outcome-based contracts, but there is little evidence the approach works. Read more article at hafana

No comments:

Post a Comment